Nektar Therapeutics NKTR Business Segments — Contract Termination Costs

Similar metrics at other companies

LOPELease Termination Costs

$327K—

OIAll Other Segments — Employee Costs Asset Impairments And Other Exit Costs

$684M+142%

BCCorporate Segment — Employee Termination and Other Benefits

$0—

SAMTermination Fee

$5M0.0%

OIAll Other Segments — Restructuring Costs And Asset Impairment Charges

$4M-83.3%

CAKEAll Other Segments — Total Costs & Expenses

$153.05M+8.7%

Questions, answered.

What is Nektar Therapeutics's business segments — contract termination costs?

Nektar Therapeutics (NKTR) reported business segments — contract termination costs of $796K in Q1 2026.

How has Nektar Therapeutics's business segments — contract termination costs changed year-over-year?

Nektar Therapeutics's business segments — contract termination costs increased by 371.0% year-over-year, from $169K to $796K.

What is the long-term trend for Nektar Therapeutics's business segments — contract termination costs?

Over 2 years (2023 to 2025), Nektar Therapeutics's business segments — contract termination costs has grown at a 58.2% compound annual growth rate (CAGR), from $1.95M to $4.89M.

What does business segments — contract termination costs mean?

Represents the expenses incurred by the segment due to the early cancellation of contracts, such as lease agreements, service provider arrangements, or supply chain commitments. These costs reflect restructuring activities or strategic shifts in operational focus within the segment. Monitoring these expenses helps investors assess the financial impact of organizational changes and efficiency initiatives.